In addition to the direct anti-tumor effect of Vγ9Vδ2 T cells, the numbers of CD4+ T and CD8+ T cells could also get increased after the allogeneic Vγ9Vδ2 T cells were transferred into the patients, as shown in another study of cholangio-carcinoma (52). The gene discussed is CD8A; the disease is neoplasm.